HIV inhibitors

US9309237B2 · kind B2 · utility

Assignees

• New York Blood Center, Inc. · US
• The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

• Asim Kumar Debnath · Fort Lee, US
• Francesca Curreli · West New York, US
• Peter Kwong · Washington, US
• Young Do Kwon · Bethesda, US

Key dates

• Filing date: Sep 6, 2012
• Grant date: Apr 12, 2016
• Expiry date: Sep 8, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Chemical compounds that inhibit retroviruses are presented herein. More particularly, this disclosure provides small molecule compounds that inhibit infection with, or treat infection caused by, human immunodeficiency viruses.